Agilent manuals, page 155
Agilent Removal of Multiple High-Abundant Proteins from Monkey Plasma for Proteomics Sample Preparation
This study describes a method based on Agilent Multiple Affinity Removal System for removing high-abundance proteins from monkey plasma, which can increase the sensitivity of detecting low-abundance proteins.
Agilent High-Purity Bacterial RNA Isolated with the Agilent Total RNA Isolation Mini Kit
A protocol for the isolation of high-purity RNA from gram-positive and gram-negative bacteria was developed for use with the Agilent Total RNA Isolation Mini Kit.
Agilent Efficient Removal of Transfected Plasmid DNA from Total Cellular RNA Prepared with Agilent s Total RNA Isolation Mini Kit
Efficient Removal of Transfected Plasmid DNA from Total Cellular RNA Prepared with Agilent Total RNA Isolation Mini Kit Application
Agilent The Agilent RNA Isolation Kit in Combination with New Agilent DNase Accessory kit Dramatically Reduces Genomic DNA Contamination of RNA Preparation
This document introduces a method for isolating total RNA samples using the Agilent Total RNA Isolation Kit and the Agilent DNase Accessory Kit, which can effectively reduce the genomic DNA contamination in total RNA samples.
Agilent Confirmation of THC in Oral Fluids Using High-Resolution 2-D GC/MS
Confirmation of THC in Oral Fluids Using High-Resolution 2-D GC/MS
Agilent An Integrated Approach to Improve Sequence Coverage Protein Identification by Combining LC-MALDI
This article introduces an integrated approach to improve sequence coverage and protein identification by combining liquid chromatography-matrix-assisted laser desorption ionization mass spectrometry (LC-MALDI MS/MS) and nanoflow liquid chromatography-tandem mass spectrometry (nano-LC/MS/MS). The coupling of RP-HPLC with MALDI via a MALDI spotting device provides an automated and robust solution for analyzing medium complexity samples using MALDI. The experimental results show that this integrated approach can improve protein coverage for complex protein samples and facilitate protein identification.
Agilent Analysis of Gene Expression Using Agilent Microarrays RNA Isolated from Human Whole Blood
This document describes Agilent's dual-mode Gene Expression Microarray platform and the method for gene expression analysis using RNA isolated from human whole blood. The platform combines the ease and simplicity of one-color experimental design with the capability of two-color sensitivity for detection of small gene expression changes. Agilent's platform now includes a method for the analysis of differential gene expression from human whole blood, which is compatible with the PAXgene™ Blood RNA System. The PAXgene Blood RNA System consists of a blood collection tube and nucleic acid purification kit for the collection, storage, and transport of blood and stabilization of intracellular RNA for subsequent isolation and purification. Combined with the PAXgene System, Agilent's amplification and labeling technology, in conjunction with the high sensitivity and specificity of 60-mer oligonucleotide microarrays, offer a total solution for gene expression in whole blood without the need for additional steps or kits to remove globin transcripts. Titration experiments using Agilent RNA spike-in control targets demonstrate the sensitivity of detection.
Agilent 10 Pitfalls of Microarray Analysis
This article introduces ten common pitfalls in DNA microarray analysis
Agilent Confirming the Presence of Drugs of Abuse in Samples Using an LC/Ion Trap Mass Spectrometer a Nearly 400 Drugs Compound Library Containing MS2 MS3 Spectra
In this work, a collision energy ramp is used in conjunction with an ion trap mass spectrometer to generate reproducible product ion spectra. For the purpose of identifying compounds in real samples, the generation of product ion spectra in those samples is also carried out using ramped collision energy. The process of confirmation includes the generating of compound spectra in the sample data, followed by NIST- based scoring of Fit, Reverse Fit, and Purity matching of library spectra. Searching of the MS spectra is not included because matrix interferences can result in poor scoring. Besides, the precursor ion spectra search is also not included because the search may result in overlapping with other compounds.
Agilent Improve Peak Shape Productivity in HPLC Analysis of Pharmaceutical Compounds with Eclipse Plus C8 Columns
This paper presents seven examples of pharmaceutical analyses employing ZORBAX Eclipse Plus C8 columns. Eclipse Plus C8 is an excellent starting point for method development because of its excellent peak shape for bases, acids, and neutrals. Excellent peak shape contributes to better peak resolution. Eclipse Plus C8 exhibits different selec- tivity compared to Eclipse XDB C8 and Eclipse Plus C18. The shorter aliphatic C8 chain is less retentive than a C18 chain and can significantly cut analysis time compared to C18. Additionally, there is a wide variety of column con- figurations available for all analytical, rapid-resolution (RR), and high-throughput analyses. Several of these examples are scaled down from analytical methods to RR methods by substituting the longer column with a RR column. This combination of excellent peak shape and scalability to high-throughput methods make Eclipse Plus C8 a valuable tool to increase productivity wherever HPLC is used.
Agilent Tailoring Speed Sensitivity Resolution in an RRHT Analysis of Cardiac Drugs
This application describes the use of Agilent ZORBAX Rapid Resolution (RR) and Rapid Resolution High Throughput (RRHT) technology to separate a variety of nitrogen-containing drugs used to treat heart disease. This method can quickly achieve the three main goals of speed, resolution, and sensitivity, and can choose different column configurations as needed.
Agilent Detection of Cannabinoids in Oral Fluid Using Inert-Source GC/MS
This article describes an analytical method for the detection of cannabinoids in oral fluid. The method utilizes an Agilent 5975 GC/MS instrument and allows for the simultaneous determination of Δ9-tetrahydrocannabinolic acid A (THCA-A), tetrahydrocannabinol (THC), cannabinol (CBN), and cannabidiol (CBD) in oral fluid samples. The method achieves the required sensitivity for the detection of THC, CBN, CBD, and THCA-A in oral fluid specimens taken from a habitual marijuana smoker.
Agilent More speed better resolution lower LOD using liquid chromatography fluorescence detection - Comparing the 1100 Series LC to the 1200 Series Rapid Resolution system
This document compares the performance differences in analyzing vitamins B2 and B6 using liquid chromatography and fluorescence detection. It compares the Agilent 1100 Series LC system with the Agilent 1200 Series Rapid Resolution LC system. The new column technology significantly improves performance, including faster run time, lower detection limit, and better resolution.
Agilent Value of Eclipse Plus C18 pH Selectivity to Analyze Amine-Containing Drugs
Agilent Advantages of Mass-based Fraction Collection
This Application Note briefly describes the advantages of mass-based fraction collection compared to time and peak based fraction collection in combination with the Agilent 1200 Series purification system and the Agilent 6100 Single Quadrupole LC/MS